Details

Last Funding Type

Series C

Industries

Biotechnology,Health Care,Medical

Founded date

Jan 1, 2009

Number Of Employee

1 - 10

Operating Status

Active

Quantapore is a biotech company developing nanopore-based nucleic acid sequencing technology. Unlike other nanopore approaches, Quantapore utilizes an optical read out which results in lower cost and higher throughput compared to electrical data acquisition.


Its novel proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The quantum-optic interaction between the nanopore and the DNA allows for single molecule nucleic acid sequencing at an unprecedented speed and cost.


Quantapore was founded by Sascha C. Dennstedt and Martin Huber in 2009.